| Year |
Citation |
Score |
| 2019 |
Hastings SB, Hariani G, Weigman VJ, Jiang T, Zhao C, Raja R, Pawlowski T, Brohawn P, Hurban P. Abstract 1346: Panel-based tumor mutational burden (TMB) analysis of matched tumor and plasma specimens using Illumina’s TruSight Oncology 500 next-generation sequencing assay Cancer Research. 79: 1346-1346. DOI: 10.1158/1538-7445.Am2019-1346 |
0.459 |
|
| 2018 |
Yourstone S, Mola N, Weigman VJ. Abstract LB-381: Effects of sequencing parameters and panel size on mutational burden calculations Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-381 |
0.426 |
|
| 2018 |
Tian Y, Jones W, Mola N, Weigman VJ. Abstract LB-380: TMB calling in absence of matched normal: Learning germline behavior Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-380 |
0.394 |
|
| 2018 |
Mola N, Schu M, Stiegelmeyer S, Jones W, Weigman VJ. Abstract 2250: Tumor mutational burden: Guidelines for derivation and robustness of measurement Cancer Research. 78: 2250-2250. DOI: 10.1158/1538-7445.Am2018-2250 |
0.41 |
|
| 2017 |
Su D, Halsey T, Buchkovich M, Powers JG, Abbott S, Shu J, Pufky J, Chang M, Weigman V, Hurban P. Abstract 5410: Optimization and evaluation of SMART-Seq v4 kit for low input RNA sequencing Cancer Research. 77: 5410-5410. DOI: 10.1158/1538-7445.Am2017-5410 |
0.346 |
|
| 2016 |
Kanai M, Schu M, Sakuma T, Abbott S, Kou T, Gagnon R, Halsey T, Matsumoto S, Kamada M, Nakatsui M, Okuno Y, Hiroshima A, Mochizuki H, Hurban P, Muto M, ... Weigman VJ, et al. Abstract 4496: Genomic profiling of late stage tumors powering precision medicine in Japan Cancer Research. 76: 4496-4496. DOI: 10.1158/1538-7445.Am2016-4496 |
0.386 |
|
| 2014 |
Bourgon R, Lu S, Yan Y, Lackner MR, Wang W, Weigman V, Wang D, Guan Y, Ryner L, Koeppen H, Patel R, Hampton GM, Amler LC, Wang Y. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2080-91. PMID 24573554 DOI: 10.1158/1078-0432.Ccr-13-3114 |
0.427 |
|
| 2012 |
Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment. 133: 865-80. PMID 22048815 DOI: 10.1007/S10549-011-1846-Y |
0.45 |
|
| 2011 |
Holbrook JD, Parker JS, Gallagher KT, Halsey WS, Hughes AM, Weigman VJ, Lebowitz PF, Kumar R. Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. Journal of Translational Medicine. 9: 119. PMID 21781349 DOI: 10.1186/1479-5876-9-119 |
0.344 |
|
| 2010 |
Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America. 107: 16910-5. PMID 20837533 DOI: 10.1073/Pnas.1009843107 |
0.408 |
|
| 2010 |
Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. The Journal of Clinical Investigation. 120: 3296-309. PMID 20679727 DOI: 10.1172/Jci41490 |
0.419 |
|
| 2009 |
Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B, Naumov G, Brandstetter KA, Weigman VJ, Zaghlul S, Hayes DN, Padera RF, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. The Journal of Clinical Investigation. 119: 2160-70. PMID 19662677 DOI: 10.1172/Jci38443 |
0.379 |
|
| 2009 |
Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, ... ... Weigman V, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Research. 69: 4116-24. PMID 19435916 DOI: 10.1158/0008-5472.Can-08-3441 |
0.397 |
|
| 2007 |
Hoadley KA, Weigman VJ, Fan C, Sawyer LR, He X, Troester MA, Sartor CI, Rieger-House T, Bernard PS, Carey LA, Perou CM. EGFR associated expression profiles vary with breast tumor subtype. Bmc Genomics. 8: 258. PMID 17663798 DOI: 10.1186/1471-2164-8-258 |
0.397 |
|
| 2007 |
Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biology. 8: R76. PMID 17493263 DOI: 10.1186/Gb-2007-8-5-R76 |
0.397 |
|
| 2004 |
Eulgem T, Weigman VJ, Chang HS, McDowell JM, Holub EB, Glazebrook J, Zhu T, Dangl JL. Gene expression signatures from three genetically separable resistance gene signaling pathways for downy mildew resistance. Plant Physiology. 135: 1129-44. PMID 15181204 DOI: 10.1104/Pp.104.040444 |
0.449 |
|
| Show low-probability matches. |